SIME:MYXSime Darby Bhd. Analysis
Data as of 2026-03-15 - not real-time
COP 9,950.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Valores Simesa S.A. is trading at 9,950 COP, perched right at its calculated resistance of 9,950 and just above its 20‑day SMA of 9,462.5, indicating a short‑term price ceiling. The 20‑, 50‑, and 200‑day moving averages (9,462.5, 8,585, and 8,044) all sit below the current price, confirming a bullish medium‑term trend. However, the 14‑day RSI of 99.9 signals extreme overbought conditions and raises the likelihood of a near‑term correction. The MACD histogram is negative (-15.5) with a bearish signal line, suggesting momentum is turning lower despite the overall bullish trend direction. Volume is on an increasing trend, which could sustain a breakout but also fuels the overbought narrative. The stock’s beta of 0.27 points to low market sensitivity, yet the 30‑day volatility of 63% reflects considerable price swings. A DCF‑derived fair value of roughly 16,557 COP implies upside of over 60% from today’s level.
Fundamentally, the company sits on a massive cash pile of 76 billion COP with zero debt, giving it a solid defensive cushion. Its price‑to‑book ratio of 0.86 places the market below intrinsic book value, reinforcing a value narrative. Conversely, earnings metrics are absent—negative EBITDA of 2.25 billion COP and a free‑cash‑flow deficit of 59.5 billion COP highlight operational weakness. Revenue growth is flat at 0% and margins are deeply negative, limiting near‑term profitability. No dividend is paid, so dividend sustainability is not applicable. The combination of high volatility, limited trading volume, and single‑country exposure to Colombia adds liquidity and geographic risk. Overall, the stock appears undervalued from a balance‑sheet perspective but faces short‑term technical headwinds and fundamental earnings challenges.
Fundamentally, the company sits on a massive cash pile of 76 billion COP with zero debt, giving it a solid defensive cushion. Its price‑to‑book ratio of 0.86 places the market below intrinsic book value, reinforcing a value narrative. Conversely, earnings metrics are absent—negative EBITDA of 2.25 billion COP and a free‑cash‑flow deficit of 59.5 billion COP highlight operational weakness. Revenue growth is flat at 0% and margins are deeply negative, limiting near‑term profitability. No dividend is paid, so dividend sustainability is not applicable. The combination of high volatility, limited trading volume, and single‑country exposure to Colombia adds liquidity and geographic risk. Overall, the stock appears undervalued from a balance‑sheet perspective but faces short‑term technical headwinds and fundamental earnings challenges.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 4/10
Key Factors
- Extreme overbought RSI
- Bearish MACD divergence
- Proximity to resistance level
Medium Term
1–3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF fair value gap
- Low price‑to‑book ratio
- Strong cash position
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued balance sheet
- Potential asset revaluation
- Low beta and defensive capital structure
Key Metrics & Analysis
Financial Health
Profit Margin232606.15%
ROE12.01%
ROA-0.67%
P/B Ratio0.9
Op. Cash FlowCOP19.6B
Free Cash FlowCOP-59480793088
Industry P/E29.1
Technical Analysis
TrendBullish
RSI99.9
SupportCOP 8,000.00
ResistanceCOP 9,950.00
MA 20COP 9,462.50
MA 50COP 8,585.00
MA 200COP 8,044.05
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueCOP 16,556.89
GradeUndervalued
TypeValue
Risk Assessment
Beta0.27
Volatility63.22%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.